{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-039959","form_type":"8-K/A","ticker":"ABSI","cik":"0001672688","company_name":"Absci Corp","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.604872+00:00","generated_at":"2026-05-17T14:38:45.620465+00:00","sec_items":["9.01","2.02","8.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Absci Q2 2025 net loss $30.6M; raises $64M in July; Almirall collaboration expands","bullets":["Q2 2025 revenue $0.6M (down from $1.3M YoY); net loss $30.6M vs $24.8M prior year.","Cash, equivalents, and ST investments $117.5M at June 30; raised ~$64M in July, extending runway into H1 2028.","Expanded Almirall AI drug discovery collaboration: second target elected, potential up to $650M in milestones across two programs.","ABS-101 (anti-TL1A) Phase 1 interim readout expected H2 2025; ABS-201 (anti-PRLR) Phase 1/2a start early 2026.","AMD strategic collaboration ongoing with $20M equity investment in Jan 2025; platform scaling using AMD Instinct accelerators."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-039959","json":"https://secwatch.observer/filing/0001628280-25-039959.json","markdown":"https://secwatch.observer/filing/0001628280-25-039959.md","text":"https://secwatch.observer/filing/0001628280-25-039959.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1672688/000162828025039959/0001628280-25-039959-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1672688/000162828025039959/absc-20250812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:38:45.620465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}